HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 2.510
-0.060 (-2.33%)
Jul 10, 2026, 11:21 AM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.47 billion as of July 9, 2026. Its market cap has decreased by -8.87% in one year.
Market Cap
1.47B
Enterprise Value
1.11B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.51
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.47B, a decrease of -76.96%. That is a compound annual growth rate of -43.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.47B | -12.88% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Frontage Holdings | 2.17B |
| PegBio | 2.15B |
| AIM Vaccine | 2.09B |
| Mabpharm | 1.75B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.66B |
| SinoMab BioScience | 1.65B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.60B |
| Zhaoke Ophthalmology | 1.44B |